Disruptive Psychopharmacology
Buch in deiner Nähe kaufen
Beschreibung
Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
Summarizes the state of the science of safety and efficacy of psychedelic therapies Reviews theoretical models and approaches to psychedelic therapies Treats both theoretical and practical aspects of psychedelic therapies
Autor*in
Frederick S. Barrett
Themen in »Disruptive Psychopharmacology«
psychedelic hallucinogen entactogen psilocybin MDMA LSD microdosing mood disorders substance use disorders addiction inflammation headache pain dementia neurodevelopmental disorders